Gkrinia Elvira Meni Maria,Belancic Andrej,Stevic Ivana,Vitezic Dinko,Jankovic Slobodan M (2026) Pharmacoeconomics of high-cost therapies: real world challenges, EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, vol. , br. , str. - (Review; Early Access) 

Belancic Andrej,Gkrinia Elvira Meni Maria,Sel Eda Kubra,Roncato Rossana,Jankovic Slobodan M,Vitezic Dinko (2026) A systematic literature review of economic evaluations of setmelanotide, EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, vol. 82, br. 5, str. - (Review) 

Gkrinia Elvira Meni Maria,Belancic Andrej,Jankovic Slobodan M (2026) Putting FAERS data into perspective: cautionary considerations for comparative safety assessment, EUROPEAN JOURNAL OF HOSPITAL PHARMACY, vol. , br. , str. - (Editorial Material; Early Access) 

Belancic Andrej,Fajkic Almir,Wah Lam Yun,Alic Lejla,Labriffe Marc,Pilipovic Kristina,Dzidic-Krivic Amina,Yee Sy Hing,Jankovic Slobodan M (2026) Microbiome-driven PKs: addressing research gaps and shaping future directions beyond the narrative review, EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, vol. , br. , str. - (Editorial Material; Early Access) 

Belancic Andrej,Jankovic Slobodan M (2026) Pharmacoeconomic digital twins: A visionary framework for the future of precision pharmacology, HEALTH POLICY AND TECHNOLOGY, vol. 15, br. 4, str. - (Editorial Material) 

Belancic Andrej,Eustaquio Patrick,Gkrinia Elvira Meni Maria,Stevic Ivana,Javor Eugen,Lam Yun Wah,Jankovic Slobodan M,Vitezic Dinko (2026) The evolving therapeutic landscape of spinal muscular atrophy - A scoping review of investigational agents, emerging delivery technologies and strategic innovations, BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, vol. , br. , str. - (Review; Early Access) 

Belancic Andrej,Fajkic Almir,Wah Lam Yun,Alic Lejla,Labriffe Marc,Pilipovic Kristina,Dzidic-Krivic Amina,Yee Sy Hing,Jankovic Slobodan M (2026) Microbiome-driven PKs: redefining drug metabolism beyond host enzymes, EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, vol. , br. , str. - (Review; Early Access) 

Belancic Andrej,Litonius Kaisa,Kulla Noora,Likic Robert,Jankovic Slobodan M,Vitezic Dinko,Backman Janne T (2025) Early-career pre-congress meetings: investing in talent, transforming the future of clinical pharmacology, EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, vol. 82, br. 1, str. - (Letter) 

Belancic Andrej,Stevic Ivana,Gkrinia Elvira Meni Maria,Vitezic Dinko,Jankovic Slobodan M (2025) Cost-utility analysis of nusinersen-risdiplam switch in patients with spinal muscular atrophy in Croatia: A discrete event simulation model, BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, vol. , br. , str. - (Article; Early Access) 

Sel Eda Kubra,Gkrinia Elvira Meni Maria,Roncato Rossana,Vitezic Dinko,Jankovic Slobodan M,Belancic Andrej (2025) Pharmacokinetics of therapies approved for spinal muscular atrophy: A narrative review of current evidence, JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, vol. 53, br. 11, str. - (Article) 

Belancic Andrej,Mas Petar,Stevic Ivana,Vitezic Dinko,Jankovic Slobodan M (2025) Diverging Safety Signals: A Trend Analysis of Suspected Adverse Drug Reactions Reporting for Spinal Muscular Atrophy Therapies in the European Union, NEUROLOGY INTERNATIONAL, vol. 17, br. 10, str. - (Article) 

Belancic Andrej,Raicevic Branislava B,Stevic Ivana,Vitezic Dinko,Jankovic Slobodan M (2025) Costs of Treating Onasemnogene Abeparvovec-Xioi-Induced Liver Injury, PHARMACOLOGY RESEARCH & PERSPECTIVES, vol. 13, br. 3, str. - (Article) 

Raicevic Branislava B,Belancic Andrej,Mirkovic Nikola F,Jankovic Slobodan M (2025) Analysis of Reporting Trends of Serious Adverse Events Associated With Anti-Obesity Drugs, PHARMACOLOGY RESEARCH & PERSPECTIVES, vol. 13, br. 2, str. - (Article)